Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 25, 2026 07:00 ET | Source: AnaCardio

AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet

Favourable safety profile in marked contrast to traditional inotropic therapeuticsAC01 showed rapid and sustained numerical improvements in cardiac output, structure and function STOCKHOLM, Sweden,...
June 25, 2026 02:00 ET | Source: AnaCardio

AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet

Favourable safety profile in marked contrast to traditional inotropic therapeuticsAC01 showed rapid and sustained numerical improvements in cardiac output, structure and function STOCKHOLM, Sweden,...